Gilead Sciences, Inc.

NasdaqGS:GILD 주식 보고서

시가총액: US$110.5b

Gilead Sciences 관리

관리 기준 확인 3/4

Gilead Sciences CEO는 Dan O'Day, Mar2019 에 임명되었습니다 의 임기는 5.67 년입니다. 총 연간 보상은 $ 22.61M, 7.7% 로 구성됩니다. 7.7% 급여 및 92.3% 보너스(회사 주식 및 옵션 포함). 는 $ 43.96M 가치에 해당하는 회사 주식의 0.04% 직접 소유합니다. 43.96M. 경영진과 이사회의 평균 재임 기간은 각각 4.8 년과 6.5 년입니다.

주요 정보

Dan O'Day

최고 경영자

US$22.6m

총 보상

CEO 급여 비율7.7%
CEO 임기5.7yrs
CEO 소유권0.04%
경영진 평균 재임 기간4.8yrs
이사회 평균 재임 기간6.5yrs

최근 관리 업데이트

We Think Some Shareholders May Hesitate To Increase Gilead Sciences, Inc.'s (NASDAQ:GILD) CEO Compensation

May 02
We Think Some Shareholders May Hesitate To Increase Gilead Sciences, Inc.'s (NASDAQ:GILD) CEO Compensation

Recent updates

We Think You Can Look Beyond Gilead Sciences' (NASDAQ:GILD) Lackluster Earnings

Nov 13
We Think You Can Look Beyond Gilead Sciences' (NASDAQ:GILD) Lackluster Earnings

Why Gilead's Solid Q3 Earnings Could Point To A Dividend Surprise Next Year

Nov 07

Gilead Sciences: My Worst Stock Move In 2024, And What I Learned From It

Oct 01

Gilead Sciences: Buy This Bargain Before It's Gone

Aug 30

Gilead's New Anti-Obesity Drug: The Real Reason Behind The 25% Stock Surge?

Aug 05

A Look At Gilead Sciences After Its Recent Weakness

Jul 27

Gilead Records Positive Phase III Results In HIV

Jun 22

Is Gilead Sciences (NASDAQ:GILD) Using Too Much Debt?

Jun 13
Is Gilead Sciences (NASDAQ:GILD) Using Too Much Debt?

Why Gilead Sciences' 4.6% Yield Doesn't Make The Cut For Smart Investors

May 23

We Think Some Shareholders May Hesitate To Increase Gilead Sciences, Inc.'s (NASDAQ:GILD) CEO Compensation

May 02
We Think Some Shareholders May Hesitate To Increase Gilead Sciences, Inc.'s (NASDAQ:GILD) CEO Compensation

Gilead Sciences, Inc.'s (NASDAQ:GILD) P/E Is On The Mark

Apr 22
Gilead Sciences, Inc.'s (NASDAQ:GILD) P/E Is On The Mark

Gilead Sciences: Some Signs Of An Impending Bottom

Apr 22

Gilead Sciences: Realizing Financial Projections Is Key

Mar 20

Gilead Sciences' (NASDAQ:GILD) Dividend Will Be Increased To $0.77

Mar 13
Gilead Sciences' (NASDAQ:GILD) Dividend Will Be Increased To $0.77

CEO 보상 분석

Dan O'Day 의 보수는 Gilead Sciences 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

US$126m

Jun 30 2024n/an/a

US$1b

Mar 31 2024n/an/a

US$485m

Dec 31 2023US$23mUS$2m

US$6b

Sep 30 2023n/an/a

US$6b

Jun 30 2023n/an/a

US$5b

Mar 31 2023n/an/a

US$6b

Dec 31 2022US$22mUS$2m

US$5b

Sep 30 2022n/an/a

US$3b

Jun 30 2022n/an/a

US$4b

Mar 31 2022n/an/a

US$5b

Dec 31 2021US$19mUS$2m

US$6b

Sep 30 2021n/an/a

US$7b

Jun 30 2021n/an/a

US$5b

Mar 31 2021n/an/a

US$301m

Dec 31 2020US$19mUS$2m

US$123m

Sep 30 2020n/an/a

US$1b

Jun 30 2020n/an/a

-US$257m

Mar 31 2020n/an/a

US$5b

Dec 31 2019US$29mUS$1m

US$5b

보상 대 시장: Dan 의 총 보상 ($USD 22.61M )은 US 시장( $USD 12.73M ).

보상과 수익: Dan 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Dan O'Day (60 yo)

5.7yrs

테뉴어

US$22,607,690

보상

Mr. Daniel P. O'Day, also known as Dan, served as Non-Executive Non-Independent Director for Galapagos NV since October 22, 2019 until March 26, 2024. He served as Member of Supervisory Board at Galapagos...

리더십 팀

이름위치테뉴어보상소유권
Daniel P. O'Day
Chairman & CEO5.7yrsUS$22.61m0.040%
$ 44.0m
Andrew Dickinson
Chief Financial Officer5yrsUS$8.11m0.011%
$ 12.3m
Deborah Telman
Executive VP of Corporate Affairs2.3yrsUS$5.27m0.0017%
$ 1.9m
Johanna Mercier
Chief Commercial Officer5.3yrsUS$8.59m0.0059%
$ 6.5m
Merdad Parsey
Chief Medical Officer5yrsUS$8.39m0.0080%
$ 8.8m
Sandra Patterson
Senior VP1.7yrs데이터 없음0.0029%
$ 3.2m
Jacquie Ross
Vice President of Investor Relations3.8yrs데이터 없음데이터 없음
Jyoti Mehra
Executive Vice President of Human Resources5.3yrs데이터 없음데이터 없음
Linda Higgins
Senior Vice President of Research4.8yrs데이터 없음데이터 없음
Rudolf Ertl
Senior Vice President of Commercial Operations of Australiano data데이터 없음데이터 없음
Flavius Martin
Executive Vice President of Research3.6yrs데이터 없음데이터 없음
William Grossman
Senior Vice President & Therapeutic Area Head of Gilead Oncology3.3yrs데이터 없음데이터 없음

4.8yrs

평균 재임 기간

58yo

평균 연령

경험이 풍부한 관리: GILD 의 관리팀은 경험 ( 4.8 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Daniel P. O'Day
Chairman & CEO5.7yrsUS$22.61m0.040%
$ 44.0m
Anthony Welters
Lead Independent Director4.1yrsUS$444.92k0.00082%
$ 905.7k
Paul Berg
Member of Scientific Advisory Boardno dataUS$16.00k데이터 없음
Jacqueline Barton
Independent Director6.8yrsUS$429.92k0.0020%
$ 2.2m
Eugene Schiff
Member of the Scientific Advisory Boardno data데이터 없음데이터 없음
Robert Schooley
Member of the Scientific Advisory Boardno data데이터 없음데이터 없음
Harish Manwani
Independent Director6.5yrsUS$414.92k0.0010%
$ 1.1m
John Mellors
Member of the Scientific Advisory Boardno data데이터 없음데이터 없음
Francis Chisari
Member of the Scientific Advisory Boardno data데이터 없음데이터 없음
Paul Klotman
Member of the Scientific Advisory Boardno data데이터 없음데이터 없음
Kelly Kramer
Independent Director8.3yrsUS$434.92k0.00011%
$ 121.5k
Joel Huff
Chairperson of Scientific Advisory Boardno data데이터 없음데이터 없음

6.5yrs

평균 재임 기간

71yo

평균 연령

경험이 풍부한 이사회: GILD 의 이사회는 경험(평균 재직 기간 6.5 년)으로 간주됩니다.